Author
Listed:
- Thomas Wilkinson
- Suereta Fortuin
- Anneke C Hesseling
- H Simon Schaaf
- Trinh Duong
- Diana M Gibb
- Susan E Purchase
- Lee Fairlie
- Suzanne Staples
- Neil Martinson
- Edina Sinanovic
- James A Seddon
Abstract
Background: Tuberculosis (TB) preventive treatment (TPT) is a core component of TB control. Levofloxacin was recently recommended by the World Health Organization as TPT in children exposed to multidrug-resistant tuberculosis (MDR-TB). However, the affordability and feasibility of TPT provision for governments, health services, individual households and global donors is uncertain. Methods: This costing analysis used empirical data collected alongside the TB-CHAMP clinical trial which investigated levofloxacin TPT in children exposed to MDR-TB in South Africa. We modelled the societal (health system and household) cost of levofloxacin TPT, other potential future (but not currently recommended) MDR-TB exposure TPT options and compared with drug-susceptible TPT options in children and adolescents under 15 years old. We modelled costs across 12 different medicine and formulation options for 11 paediatric dosing weight-bands using TB-CHAMP and household survey data, with national and international procurement medicine pricing. Results: Total societal costs of providing levofloxacin TPT and its monitoring per child were US$252 (0-
Suggested Citation
Thomas Wilkinson & Suereta Fortuin & Anneke C Hesseling & H Simon Schaaf & Trinh Duong & Diana M Gibb & Susan E Purchase & Lee Fairlie & Suzanne Staples & Neil Martinson & Edina Sinanovic & James A Se, 2026.
"Health system and household costs of preventive treatment delivery for children exposed to multidrug-resistant tuberculosis in South Africa,"
PLOS ONE, Public Library of Science, vol. 21(10), pages 1-16, October.
Handle:
RePEc:plo:pone00:0336561
DOI: 10.1371/journal.pone.0336561
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0336561. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.